重症监护中的促动力药物。
Prokinetic agents in critical care.
作者信息
Doherty Warren L, Winter Bob
机构信息
Adult Intensive Care Unit, University Hospital, Queen's Medical Centre, Nottingham, UK.
出版信息
Crit Care. 2003 Jun;7(3):206-8. doi: 10.1186/cc1849. Epub 2003 Jan 10.
Abstract
Prokinetic agents are commonly used in intensive care, mainly to aid in early enteral feeding. The present commentary reviews some of the recently published papers and highlights the lack of a sizable evidence base, as well as the possible importance of euglycaemia in this important clinical area.
摘要
促动力药常用于重症监护，主要是为了辅助早期肠内喂养。本评论回顾了一些最近发表的论文，并强调了缺乏大量证据基础，以及血糖正常在这一重要临床领域可能的重要性。
相似文献
1
Prokinetic agents in critical care.
Crit Care. 2003 Jun;7(3):206-8. doi: 10.1186/cc1849. Epub 2003 Jan 10.
2
Comment on: The use of erythromycin as a gastrointestinal prokinetic agent in adult critical care: benefits versus risks.
J Antimicrob Chemother. 2008 Jan;61(1):227; author reply 227-8. doi: 10.1093/jac/dkm419. Epub 2007 Nov 2.
3
Promotility agents in the intensive care unit.
Crit Care Med. 2000 Jul;28(7):2657-9. doi: 10.1097/00003246-200007000-00085.
4
The use of erythromycin as a gastrointestinal prokinetic agent in adult critical care: benefits versus risks.
J Antimicrob Chemother. 2007 Mar;59(3):347-58. doi: 10.1093/jac/dkl537. Epub 2007 Feb 8.
5
Motility disorders in the ICU: recent therapeutic options and clinical practice.
Curr Opin Clin Nutr Metab Care. 2009 Mar;12(2):161-7. doi: 10.1097/MCO.0b013e32832182c4.
6
How should we use prokinetic drugs in patients who are intolerant to enteral feeding?
Crit Care Med. 2007 Feb;35(2):650-1. doi: 10.1097/01.CCM.0000255158.57077.8E.
7
[Effects of various prokinetic drugs on gastrointestinal transit times in patients with progressive systemic scleroderma].
Z Gastroenterol. 1997 Oct;35(10):905-12.
8
Sequential single doses of cisapride, erythromycin, and metoclopramide in critically ill patients intolerant to enteral nutrition: a randomized, placebo-controlled, crossover study.
Crit Care Med. 2000 Feb;28(2):438-44. doi: 10.1097/00003246-200002000-00025.
9
[Promotility drugs use in critical care: indications and limits?].
Ann Fr Anesth Reanim. 2009 Nov;28(11):962-75. doi: 10.1016/j.annfar.2009.08.008. Epub 2009 Nov 11.
10
Practicalities of nutrition support in the intensive care unit: the usefulness of gastric residual volume and prokinetic agents with enteral nutrition.
Nutrition. 2011 May;27(5):509-12. doi: 10.1016/j.nut.2010.10.010. Epub 2011 Feb 4.
引用本文的文献
1
Use of prokinetic agents in hospitalised adult patients: Protocol for a scoping review.
Acta Anaesthesiol Scand. 2022 Sep;66(8):1024-1026. doi: 10.1111/aas.14099. Epub 2022 Jun 22.
2
Comparing the Effect of Neostigmine and Metoclopramide on Gastric Residual Volume of Mechanically Ventilated Patients in Intensive Care Unit: A Double-Blind Randomized Clinical Trial.
Biomed Res Int. 2021 Aug 16;2021:5550653. doi: 10.1155/2021/5550653. eCollection 2021.
3
Selective toxicity of antibacterial agents-still a valid concept or do we miss chances and ignore risks?
Infection. 2021 Feb;49(1):29-56. doi: 10.1007/s15010-020-01536-y. Epub 2020 Dec 23.
4
A Double-Blind Randomized Clinical Trial Comparing the Effect of Neostigmine and Metoclopramide on Gastric Residual Volume of Mechanically Ventilated ICU Patients.
Acta Inform Med. 2016 Dec;24(6):385-389. doi: 10.5455/aim.2016.24.385-389.
5
Acupuncture in critically ill patients improves delayed gastric emptying: a randomized controlled trial.
Anesth Analg. 2011 Jan;112(1):150-5. doi: 10.1213/ANE.0b013e3181fdfac8. Epub 2010 Nov 16.
6
Erythromycin for prokinesis: imprudent prescribing?
Crit Care. 2006 Feb;10(1):112. doi: 10.1186/cc3956.
本文引用的文献
1
Promoting enteral feeding 101.
Crit Care Med. 2002 Jul;30(7):1653-4. doi: 10.1097/00003246-200207000-00044.
2
Gastrointestinal promotility drugs in the critical care setting: a systematic review of the evidence.
Crit Care Med. 2002 Jul;30(7):1429-35. doi: 10.1097/00003246-200207000-00005.
3
Gastric prokinetic motility therapy to facilitate early enteral nutrition in the intensive care unit.
Crit Care Med. 2002 Jun;30(6):1386-7. doi: 10.1097/00003246-200206000-00046.
4
Erythromycin and early enteral nutrition in mechanically ventilated patients.
Crit Care Med. 2002 Jun;30(6):1237-41. doi: 10.1097/00003246-200206000-00012.
5
Early enteral nutrition in acutely ill patients: a systematic review.
Crit Care Med. 2001 Dec;29(12):2264-70. doi: 10.1097/00003246-200112000-00005.
6
Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial.
Gut. 2001 Sep;49(3):395-401. doi: 10.1136/gut.49.3.395.
7
What comes after macrolides and other motilin stimulants?
Gut. 2001 Sep;49(3):317-8. doi: 10.1136/gut.49.3.317.
8
Erythromycin improves gastric emptying in critically ill patients intolerant of nasogastric feeding.
Crit Care Med. 2000 Jul;28(7):2334-7. doi: 10.1097/00003246-200007000-00026.
9
The effect of erythromycin on gastric emptying is modified by physiological changes in the blood glucose concentration.
Am J Gastroenterol. 1999 Aug;94(8):2074-9. doi: 10.1111/j.1572-0241.1999.01280.x.
10
Metoclopramide improves gastric motility in critically ill patients.
Intensive Care Med. 1999 May;25(5):464-8. doi: 10.1007/s001340050881.
Zotero 插件